Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.422 SEK | -13.17% |
|
-13.52% | -89.44% |
05-22 | Transcript : Scandion Oncology A/S, Q1 2024 Earnings Call, May 22, 2024 | |
05-22 | Scandion Oncology A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.89M | - | - | - | - | - | |
124B | ||||||
111B | ||||||
23.17B | - | |||||
22.94B | - | |||||
17.42B |